combined treatment
In the present study, we investigated the       effect of combined treatment with a humanized anti-HER2 monoclonal antibody,       rhumAbHER2 (trastuzumab), and an anti-oestrogen, ICI 182,780, on the cell growth        of three human breast cancer cell lines which respectively express different       levels of ER and HER2.
In the present study, we investigated the       effect of  @SUBJECT$   @PREDICAT$  a humanized anti- @OBJECT$ ,       rhumAbHER2 (trastuzumab), and an anti-oestrogen, ICI 182,780, on the cell growth        of three human breast cancer cell lines which respectively express different       levels of ER and HER2.